Marimed (MRMD) Enterprise Value (2016 - 2025)
Marimed (MRMD) has disclosed Enterprise Value for 15 consecutive years, with -$8.4 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value rose 26.89% to -$8.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.4 million, a 26.89% increase, with the full-year FY2024 number at -$9.0 million, up 44.86% from a year prior.
- Enterprise Value was -$8.4 million for Q3 2025 at Marimed, down from -$7.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$7.9 million in Q2 2025 to a low of -$36.3 million in Q1 2022.
- A 5-year average of -$16.2 million and a median of -$14.2 million in 2021 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: crashed 604.46% in 2021, then soared 63.9% in 2022.
- Marimed's Enterprise Value stood at -$31.5 million in 2021, then skyrocketed by 63.9% to -$11.4 million in 2022, then plummeted by 44.08% to -$16.4 million in 2023, then skyrocketed by 44.86% to -$9.0 million in 2024, then increased by 6.74% to -$8.4 million in 2025.
- Per Business Quant, the three most recent readings for MRMD's Enterprise Value are -$8.4 million (Q3 2025), -$7.9 million (Q2 2025), and -$9.0 million (Q1 2025).